Login to Your Account

Other News To Note

Tuesday, October 2, 2012
• AvidBiotics Corp., of South San Francisco, said it received a two-year, $600,000 grant from the National Institute of Allergy and Infectious Diseases to further develop its targetable bactericidal proteins against Clostridium difficile bacteria.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription